Neuronetics has received US Food and Drug Administration (FDA) clearance for its NeuroSite Coil placement accessory, a tool that helps users with accurate coil placement.
US-based Neuronetics was the first company to receive FDA approval for its transcranial magnetic stimulation (TMS) devices called NeuroStar for treatment-resistant depression. The devices use a coil to deliver magnetic pulses that stimulate nerve cells in the brain in regions responsible for mood regulation.
The add-on will help with coil positioning and placement and reduce patient setup time, with Neuronetics stating the device is compatible with both legacy and new NeuroStar systems.
